We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Ethicon has announced the results of a study demonstrating that the company's
ULTRAPRO Partially Absorbable Lightweight Mesh provides high initial burst strength
during the critical time period of tissue-mesh incorporation.
Biophan Technologies, a developer of next-generation biomedical technology,
entered into a letter of intent to acquire a leading German-based developer
of magnetic resonance imaging (MRI)-safe and image-compatible technology solutions
and biomedical devices.
Biofield, developer of the Biofield Breast Proliferation Rate Detection System
(BDS) -- a noninvasive, radiation-free adjunctive test system that may be of
assistance in the evaluation of suspicious breast lesions -- has submitted a
petition to the FDA requesting reclassification of the BDS.
NIR Diagnostics, a leading-edge developer of near-infrared
diagnostic instruments, has received a $1 million payment as a result of a licensing
agreement between Spectromedical, of Cambridge, Ontario, and a third-party licensee.
DOBI Medical International has expanded its international presence by signing
new distribution agreements with Biomedica Life Sciences in Athens, Greece,
and Nova-Logic in Montreux, Switzerland, for the DOBI Medical ComfortScan system.
I-Flow announced that Volker Jacobs and John Morrison of the Fayette Medical
Center (FMC) presented data highlighting benefits of ON-Q PainBuster to reduce
pain after mastectomy while reducing or eliminating the use of narcotics at
the San Antonio Breast Cancer Symposium in December.
Medical device company American Bio Medica has said that the FDA cleared its
Rapid TEC4 drugs of abuse test and also received a Canadian patent related to
its rapid drug screen product.
CryoFluor Therapeutics, a medical device company developing a novel cryosurgical
technology platform, has received a second investment that will allow the company
to complete a feasibility clinical trial of its device to treat abnormal uterine
bleeding.
RITA Medical Systems has announced its wholly owned subsidiary Horizon Medical
Products entered into an agreement allowing it to repay $6.5 million in debt
held by creditors of Horizon.
AMDL, developer and marketer of tests for the early detection of cancer and
other serious diseases, has announced its consultant, Diagnostic Oncology Clinical
Research Organization, submitted to the FDA, on behalf of AMDL, additional data
and a new application for 510(k) clearance to market AMDL's DR-70 test as an
aid in monitoring patients previously diagnosed with progressing colorectal
cancer.
Nanogen, developer of advanced diagnostic products, has announced the appointment
of Robert Saltmarsh as CFO. Saltmarsh joined Nanogen as vice president of corporate
development last September.
Recom Managed Systems, in conjunction with the Duke Clinical Research Institute,
of Durham, N.C., has announced its Sponsored Research trial is underway.